MSQ Webinar: Unveiling What's New, Expert Insights and Partnership Opportunities in Targeted Protein Degradation (TPD)
In the surge of TPD drug development, we are excited to invite you to join our upcoming MSQ Webinar together with MNCs who heavily invest in TPD, emerging TPD global players and dealmakers, co-hosted by MSQ Ventures and BioAroundWorld. The discussion will cover the latest breakthrough and trends in this rapidly evolving space and offer insights into how to leverage partnership to monetize the pipeline and achieve greater success together.
EVENT SCHEDULE
Unveiling What's New, Expert Insights and Partnership Opportunities in Targeted Protein Degradation – PART 1
DATE: August 10th, 2023
TIME: 9:00 – 10:00 AM EST / 9:00 – 10:00 PM BJT
Moderator: Ginger Ding, Managing Director, MSQ Ventures
Speakers:
Michael Palladinetti, Global Head of BD & Licensing, Sanofi
Scott Boyle, CBO, C4 Therapeutics
Tom Shepherd, CEO, Captor Therapeutics
Xiaobao Yang, CEO, Gluetacs Therapeutics
Leo Fu, Co-Founder, GluBio Therapeutics
Ruo Xu, VP of BD, Kintor Pharma
UNVEILING WHAT'S NEW, EXPERT INSIGHTS AND PARTNERSHIP OPPORTUNITIES IN TARGETED PROTEIN DEGRADATION – PART 2
DATE: August 24th, 2023
TIME: 9:00 – 10:00 AM EST / 9:00 – 10:00 PM BJT
Moderator: Echo Hindle-Yang, President & CEO, MSQ Ventures
Speakers:
Nikhil Mutyal, Executive Director, BD&L, Merck
Randy Teel, SVP of corporate and BD, Arvinas
Lily Zou, CEO, Degron Therapeutics
Sahm Nasseri, CBO, Biotheryx
Can’t attend live? Register anyway, and we’ll send you the session recording after the event. Following the webinar, attendees will also have the chance to schedule a one-on-one session with BiOneCure through MSQ.